Thornburg Investment Management Inc Horizon Therapeutics Public LTD CO Transaction History

Thornburg Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $7.68 Million - $14 Million	-123,156 Reduced 50.31%	121,656 $13.8 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $7.5 Million - $10.8 Million	127,277 Added 108.29%	244,812 $15.2 Million
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $2.2 Million - $3.22 Million	-27,675 Reduced 19.06%	117,535 $9.38 Million
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $287,260 - $365,008	-3,324 Reduced 2.24%	145,210 $15.3 Million
Q4 2021 Feb 10, 2022	SELL	$98.56 - $119.91 $3.69 Million - $4.49 Million	-37,482 Reduced 20.15%	148,534 $16 Million
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $27.2 Million - $32.7 Million	-296,240 Reduced 61.43%	186,016 $20.4 Million
Q2 2021 Aug 11, 2021	SELL	$86.24 - $95.92 $1.34 Million - $1.49 Million	-15,578 Reduced 3.13%	482,256 $45.2 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $2.39 Million - $3.18 Million	-33,261 Reduced 6.26%	497,834 $45.8 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $35.6 Million - $44.8 Million	531,095 New	531,095 $38.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Thornburg Investment Management Inc with notifications on news.